Journal
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION
Volume 41, Issue 4, Pages 221-226Publisher
AMER ANIMAL HOSPITAL ASSOC
DOI: 10.5326/0410221
Keywords
-
Categories
Ask authors/readers for more resources
Combination chemotherapy is superior to single-agent chemotherapy for treating canine lymphoma, but the effect of each drug on efficacy remains unknown. By comparing 34 dogs treated with a modified cyclophosphamide, vincristine, prednisone (COP) chemotherapy protocol and 42 dogs given asparaginase in the induction phase of the same protocol, the effect of asparaginase on the chemotherapeutic protocol was determined. Both groups were compared based on clinical response at 2 weeks and 6 weeks, and on the progression-free interval. Asparaginase did not significantly increase the likelihood of a clinical remission or prolong the initial progression-free interval in the dogs studied.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available